About These Sessions Roy Wallen leads Directional Healthcare Advisors, a NH-based advisory services firm.  He has served in leadership roles for new product initiatives in medical technology companies ranging from pre-revenue start-up to multi-billion, global concerns.  Roy has spent his career managing existing businesses for sustainable profits and bringing new technologies out of the laboratory and into clinical use.  His focus is on market development based on research and a planning process that addresses market access needs.  Roy also serves…

About These Sessions Roy Wallen leads Directional Healthcare Advisors, a NH-based advisory services firm.  He has served in leadership roles for new product initiatives in medical technology companies ranging from pre-revenue start-up to multi-billion, global concerns.  Roy has spent his career managing existing businesses for sustainable profits and bringing new technologies out of the laboratory and into clinical use.  His focus is on market development based on research and a planning process that addresses market access needs.  Roy also serves…

About These Sessions Roy Wallen leads Directional Healthcare Advisors, a NH-based advisory services firm.  He has served in leadership roles for new product initiatives in medical technology companies ranging from pre-revenue start-up to multi-billion, global concerns.  Roy has spent his career managing existing businesses for sustainable profits and bringing new technologies out of the laboratory and into clinical use.  His focus is on market development based on research and a planning process that addresses market access needs.  Roy also serves…

About These Sessions Roy Wallen leads Directional Healthcare Advisors, a NH-based advisory services firm.  He has served in leadership roles for new product initiatives in medical technology companies ranging from pre-revenue start-up to multi-billion, global concerns.  Roy has spent his career managing existing businesses for sustainable profits and bringing new technologies out of the laboratory and into clinical use.  His focus is on market development based on research and a planning process that addresses market access needs.  Roy also serves…

About These Sessions Roy Wallen leads Directional Healthcare Advisors, a NH-based advisory services firm.  He has served in leadership roles for new product initiatives in medical technology companies ranging from pre-revenue start-up to multi-billion, global concerns.  Roy has spent his career managing existing businesses for sustainable profits and bringing new technologies out of the laboratory and into clinical use.  His focus is on market development based on research and a planning process that addresses market access needs.  Roy also serves…

About These Sessions Roy Wallen leads Directional Healthcare Advisors, a NH-based advisory services firm.  He has served in leadership roles for new product initiatives in medical technology companies ranging from pre-revenue start-up to multi-billion, global concerns.  Roy has spent his career managing existing businesses for sustainable profits and bringing new technologies out of the laboratory and into clinical use.  His focus is on market development based on research and a planning process that addresses market access needs.  Roy also serves…

About These Sessions Roy Wallen leads Directional Healthcare Advisors, a NH-based advisory services firm.  He has served in leadership roles for new product initiatives in medical technology companies ranging from pre-revenue start-up to multi-billion, global concerns.  Roy has spent his career managing existing businesses for sustainable profits and bringing new technologies out of the laboratory and into clinical use.  His focus is on market development based on research and a planning process that addresses market access needs.  Roy also serves…

About These Sessions Roy Wallen leads Directional Healthcare Advisors, a NH-based advisory services firm.  He has served in leadership roles for new product initiatives in medical technology companies ranging from pre-revenue start-up to multi-billion, global concerns.  Roy has spent his career managing existing businesses for sustainable profits and bringing new technologies out of the laboratory and into clinical use.  His focus is on market development based on research and a planning process that addresses market access needs.  Roy also serves…